Degryse AD - Search Results

1

Classification and reporting of severity experienced by animals used in scientific procedures: FELASA/ECLAM/ESLAV Working Group report.

Smith D, Anderson D, Degryse AD, Bol C, Criado A, Ferrara A, Franco NH, Gyertyan I, Orellana JM, Ostergaard G, Varga O, Voipio HM. Smith D, et al. Among authors: degryse ad. Lab Anim. 2018 Feb;52(1_suppl):5-57. doi: 10.1177/0023677217744587. Lab Anim. 2018. PMID: 29359995 Free PMC article.

2

Assessable learning outcomes for the EU Education and Training Framework core and Function A specific modules: Report of an ETPLAS WORKING Group.

Dontas IA, Applebee K, Vlissingen MFV, Galligioni V, Marinou K, Ryder K, Schenkel J, Prins JB, Degryse AD, Lewis DI. Dontas IA, et al. Among authors: degryse ad. Lab Anim. 2021 Jun;55(3):215-232. doi: 10.1177/0023677220968589. Epub 2020 Dec 7. Lab Anim. 2021. PMID: 33287628 Free PMC article.

3

Pharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse model.

Lauressergues E, Heusler P, Lestienne F, Troulier D, Rauly-Lestienne I, Tourette A, Ailhaud MC, Cathala C, Tardif S, Denais-Laliève D, Calmettes MT, Degryse AD, Dumoulin A, De Vries L, Cussac D. Lauressergues E, et al. Among authors: degryse ad. Pharmacol Res Perspect. 2016 Mar 4;4(2):e00214. doi: 10.1002/prp2.214. eCollection 2016 Apr. Pharmacol Res Perspect. 2016. PMID: 27069629 Free PMC article.

4

ESLAV/ECLAM/LAVA/EVERI recommendations for the roles, responsibilities and training of the laboratory animal veterinarian and the designated veterinarian under Directive 2010/63/EU.

Poirier GM, Bergmann C, Denais-Lalieve DG, Dontas IA, Dudoignon N, Ehall H, Fentener van Vlissingen JM, Fornasier M, Kalman R, Hansen A, Schueller S, Vergara P, Weilenmann R, Wilson J, Degryse AD. Poirier GM, et al. Among authors: degryse ad. Lab Anim. 2015 Apr;49(2):89-99. doi: 10.1177/0023677214557717. Epub 2014 Nov 21. Lab Anim. 2015. PMID: 25416607

5

Cardioprotection of cariporide evaluated by plasma myoglobin and troponin I in myocardial infarction in pigs.

Létienne R, Bel L, Bessac AM, Denais D, Degryse AD, John GW, Le Grand B. Létienne R, et al. Among authors: degryse ad. Fundam Clin Pharmacol. 2006 Apr;20(2):105-13. doi: 10.1111/j.1472-8206.2006.00394.x. Fundam Clin Pharmacol. 2006. PMID: 16573710

6

The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.

Kiss I, Degryse AD, Bardin L, Gomez de Segura IA, Colpaert FC. Kiss I, et al. Among authors: degryse ad. Eur J Pharmacol. 2005 Oct 31;523(1-3):29-39. doi: 10.1016/j.ejphar.2005.09.003. Epub 2005 Oct 13. Eur J Pharmacol. 2005. PMID: 16226246

7

Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits.

Rival Y, Junquéro D, Bruniquel F, N'Guyen X, Fauré P, Pomiès JP, Degryse AD, Delhon A. Rival Y, et al. Among authors: degryse ad. J Cardiovasc Pharmacol. 2002 Feb;39(2):181-91. doi: 10.1097/00005344-200202000-00004. J Cardiovasc Pharmacol. 2002. PMID: 11791003

8

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.

Junquero D, Bruniquel F, N'Guyen X, Autin JM, Patoiseau JF, Degryse AD, Colpaert FC, Delhon A. Junquero D, et al. Among authors: degryse ad. Atherosclerosis. 2001 Mar;155(1):131-42. doi: 10.1016/s0021-9150(00)00559-1. Atherosclerosis. 2001. PMID: 11223434

9

Ethics committee recommendations for laboratory animals in private research in France.

Verschuere B, Autissier C, Degryse AD, Gallix P, Gotti B, Laurent J, Leinot M, Peyclit I; GRICE(Interprofessional Working Group on Ethics Committees for Laboratory Animals/Groupe de Reflexion Interprofessionnel sur les Comites d'Ethique appliquee a la animalde laboratoire). Verschuere B, et al. Among authors: degryse ad. Lab Anim. 2000 Jul;34(3):236-43. doi: 10.1258/002367700780384690. Lab Anim. 2000. PMID: 11037116

10

Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.

Oms P, Assie N, Bruniquel F, Degryse AD, van Haverbeke G, Delhon A. Oms P, et al. Among authors: degryse ad. Pharmacol Toxicol. 1995 Dec;77(6):391-6. doi: 10.1111/j.1600-0773.1995.tb01048.x. Pharmacol Toxicol. 1995. PMID: 8835365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page